Medication info
Selavix Tablet 75 mg (Clopidogrel Sulfate)

Selavix Tablet 75 mg (Clopidogrel Sulfate)

Prescription medicationTablet
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Celltrion Pharmaceutical Co., Ltd.
Appearance
Pink, round, film-coated tablet
Packaging
30 tablets (10 tablets/Alu-Alu *3)
Approval status
Active

MFDS item code 201701198 · Approved 2017.03.09 · Insurance code 693902400

Summary

Main use
Improvement of symptoms of atherosclerosis and acute coronary syndrome; prevention of thromboembolism in atrial fibrillation
Who uses it
Adults
Adult dosage
○ Adults 1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of this medication 300 mg once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be coadministered with this medication once daily. 3. In patients with atrial fibrillation, administer this medication 75 mg orally once daily. Aspirin 75 ~ 100 mg should be coadministered with this medication once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate liver disease and a bleeding diathesis is limited. This medication may be administered without regard to food.

Ingredients

Manufacturer
Celltrion Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of symptoms of atherosclerosis and acute coronary syndrome; prevention of thromboembolism in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral arterial disease
  • acute coronary syndrome
  • unstable angina
  • non-Q-wave myocardial infarction
  • cardiovascular anomalies
  • stroke
  • refractory ischemia
  • vascular risk factors
  • bleeding risk
  • atrial fibrillation
View approved original text

This medication is used to improve symptoms of various cardiovascular-related diseases. It first improves atherosclerotic symptoms in adult patients with ischemic stroke, myocardial infarction, or peripheral arterial disease. Additionally, it helps improve atherosclerotic symptoms such as death due to cardiovascular issues, myocardial infarction, stroke, or refractory ischemia in adult patients with acute coronary syndrome. Meanwhile, in patients with atrial fibrillation who have vascular risk factors, where vitamin K antagonists are unsuitable and the risk of bleeding is low, it is used to reduce the risk of thrombosis such as stroke. It is effectively utilized in improving symptoms of patients with various cardiovascular diseases and risk factors.

Dosage and Administration

Adult dosage

○ Adults 1. In patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. In patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of this medication 300 mg once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be coadministered with this medication once daily. 3. In patients with atrial fibrillation, administer this medication 75 mg orally once daily. Aspirin 75 ~ 100 mg should be coadministered with this medication once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate liver disease and a bleeding diathesis is limited. This medication may be administered without regard to food.

Precautions

This medication prevents blood platelets from aggregating to prevent blood clotting. Firstly, this medication is affected by the function of the specific enzyme CYP2C19 in the liver. Individuals with genetically reduced function of this enzyme may have decreased medication effectiveness, thereby increasing the risk of heart or vascular issues. Moreover, taking medications that activate the CYP2C19 enzyme along with this medication can increase the concentration of the active ingredient, elevating the risk of bleeding. Taking such medications together is not recommended. This medication should not be used in certain situations. For example, individuals allergic to this medication or its ingredients, those who currently have bleeding, individuals with severe liver dysfunction, breastfeeding women, and those with genetic issues like lactose intolerance should not take it. Patients with a high risk of bleeding or bleeding disorders, those with decreased liver or kidney function, patients who recently suffered a stroke, individuals with severe hypertension, elderly patients, underweight individuals, and those allergic to similar medications should use this medication with caution. During treatment, if symptoms of bleeding or abnormal reactions occur, immediate consultation with a doctor is advised, and if surgery is planned, this medication can be discontinued 5-7 days prior to the surgery. This medication may increase the risk of bleeding, so it is particularly important to exercise caution when taken with other drugs related to bleeding risk. For instance, co-administration with aspirin, non-steroidal anti-inflammatory drugs, anticoagulants, or selective serotonin reuptake inhibitors (SSRIs) may heighten the risk of bleeding. During pregnancy, the risk to the fetus is not high, but there is a bleeding risk during childbirth, so caution is warranted. If breastfeeding, consideration should be given to stopping breastfeeding or discontinuing the medication due to the potential for the drug to be excreted in breast milk. Safety and efficacy in children have not been established, and seniors are at a higher risk of bleeding, thus requiring dosage adjustment and condition monitoring. In cases of overdose, the risk of significant bleeding may increase, so caution is advised. In emergencies, platelet transfusion can reverse the effects of the medication. Finally, this medication should be stored out of the reach of children, and transferring it to another container is not advisable for quality maintenance.

Side effects

  • Hemorrhage
  • gastrointestinal bleeding
  • purpura
  • contusion
  • hematoma
  • nosebleed
  • hematoma
  • hematuria
  • intraocular hemorrhage
  • intracranial hemorrhage
Show 102 more
  • severe neutropenia
  • aplastic anemia
  • thrombocytopenia
  • gastrointestinal symptoms
  • abdominal pain
  • dyspepsia
  • gastritis
  • constipation
  • diarrhea
  • rash
  • pruritus
  • headache
  • dizziness
  • chest pain
  • accidental injury
  • influenza-like illness
  • pain
  • fatigue
  • edema
  • hypertension
  • depression
  • upper respiratory tract infection
  • dyspnea
  • rhinitis
  • bronchitis
  • cough
  • urinary tract infection
  • allergic symptoms
  • ischemic necrosis
  • gastritis
  • hemorrhagic gastritis
  • duodenal ulcer
  • gastric ulcer
  • perforated gastric ulcer
  • upper gastrointestinal ulcer bleeding
  • bloating
  • hyperbilirubinemia
  • infectious hepatitis
  • fatty liver
  • hemorrhagic arthropathy
  • hematuria
  • hemoptysis
  • intracranial hemorrhage
  • retroperitoneal hemorrhage
  • ocular hemorrhage
  • pulmonary hemorrhage
  • purpura
  • thrombocytopenia
  • anemia
  • aplastic anemia
  • hypochromic anemia
  • agranulocytosis
  • granulocytopenia
  • leukemia
  • leukopenia
  • neutropenia
  • eosinophilia
  • menorrhagia
  • hemorrhagic pleurisy
  • herpes zoster
  • erythematous rash
  • maculopapular rash
  • urticaria
  • renal dysfunction
  • acute renal failure
  • fever
  • anorexia
  • weight loss
  • visual disturbances
  • hypomania
  • weight gain
  • facial flushing
  • decreased motor function
  • thirst
  • forgetfulness
  • abnormal thoughts
  • pollakiuria
  • arrhythmia
  • tremor
  • speech impairment
  • abnormal gait
  • hyperactivity
  • ataxia
  • hiccup
  • dysphagia
  • abnormal behavior
  • rigidity
  • visual disturbance
  • dry eye syndrome
  • transient blindness
  • congestion
  • micturition disorder
  • uremia
  • hypoglycemia
  • bradycardia
  • tinnitus
  • contact dermatitis
  • gynecomastia
  • elevated PSA
  • cholecystitis
  • hematemesis
  • spinal hematoma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. The storage temperature should be maintained between 1 degree and 30 degrees Celsius to effectively preserve the medication's efficacy and safety.

Appearance and packaging

Appearance

Pink, round, film-coated tablet

Package unit

30 tablets (10 tablets/Alu-Alu *3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.